Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1997 Jul;14(6):328-31.
doi: 10.1007/BF02765836.

Gonadotropins and glucocorticoid therapy for "low responders"--a controlled study

D Bider  1 , J Blankstein, J Levron, I Tur-Kaspa
Affiliations
Clinical Trial

Gonadotropins and glucocorticoid therapy for "low responders"--a controlled study

D Bider et al. J Assist Reprod Genet. 1997 Jul.

Abstract

Purpose: A randomized, nonplacebo controlled study was conducted to determine the effect of dexamethasone supplementation to a protocol of gonadotropin therapy in 42 "low-responder patients" aged 32 to 43 years.

Methods: All underwent at least two previous cycles treated by gonadotropins for unexplained infertility, or anovulation. Human menopausal gonadotropin was started on day 4 of the menstrual cycle combined with dexamethasone 0.5 mg administered nightly, as an adjuvant. A group of "low responders" who did not receive dexamethasone served as the controls. The number of follicles, total amount of gonadotropins used, time required for stimulation, fertilization, peak estradiol levels and pregnancy rate were evaluated.

Results: The number of developing follicles, estradiol levels, fertilization rate and pregnancy rate did not differ significantly.

Conclusions: Although certain beneficial effects were observed in the literature in some of the infertile patients treated with corticosteroids, the overall results did not support daily, low-dose dexamethasone (long-acting corticosteroid) as a clinically useful adjuvant therapy for "low responders" during gonadotropin therapy.

PubMed Disclaimer

References

    1. Frydman R, Fanchin R. Flare-up protocols in assisted reproductive technologies (ART): A re-evaluation. In: Filicori M., Flamigni C., editors. Ovulation Induction: Basic Science and Clinical Advances. Amsterdam: Excerpta Medica; 1980. pp. 283–289.
    1. Hugues JN, Torresani T, Herve F, Martin-Pont B, Tamboise A, Santarelli J. Interest of growth hormone-releasing hormone administration for improvement of ovarian responsiveness to gonadotropins in poor responder women. Fertil Steril. 1991;55:945–951. - PubMed
    1. Hughes SM, Huang ZH, Morris ID, Matson PL, Buck P, Lieberman BA. A double-blind cross-over controlled study to evaluate the effect of human biosynthetic growth hormone on ovarian stimulation in previous poor responders to in-vitro fertilization. Hum Reprod. 1994;9:13–18. - PubMed
    1. Dor J, Seidman DS, Amudai E, Bider D, Levran D, Maschiach S. Adjuvant growth hormone therapy in poor responders to invitro fertilization: A prospective randomized placebo-controlled double-blind study. Hum Reprod. 1995;10:40–43. doi: 10.1093/humrep/10.1.40. - DOI - PubMed
    1. O’Shea DL, Kettel M, Isaacs JD, Olive DL, Radwanska E, Odem RR. Ovulation induction in the poor responder or hyperresponder. Am J Obstet Gynecol. 1995;172:788–791. doi: 10.1016/0002-9378(95)90156-6. - DOI - PubMed

MeSH terms